Eluxadoline
|
- $63 - $640
- Product name: Eluxadoline
- CAS: 864821-90-9
- MF: C32H35N5O5
- MW: 569.65
- EINECS:1592732-453-0
- MDL Number:MFCD28386164
- Synonyms:JNJ 27018966;Eluxadoline;5-(((S)-2-amino-3-(4-carbamoyl-2,6-dimethylphenyl)-N-((S)-1-(4-phenyl-1H-imidazol-2-yl)ethyl)propanamido)methyl)-2-methoxybenzoic acid;Eluxadolin;API-Diarrhea;Benzoic acid, 5-[[[(2S)-2-amino-3-[4-(aminocarbonyl)-2,6-dimethylphenyl]-1-oxopropyl][(1S)-1-(5-phenyl-1H-imidazol-2-yl)ethyl]amino]methyl]-2-methoxy-;CS-2329;Eluxadoline (Viberzi)
7 prices
Selected condition：
Brand
- American Custom Chemicals Corporation
- Cayman Chemical
- DC Chemicals
- TRC
Package
- 5MG
- 10mg
- 25mg
- 50mg
- 100mg
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberAPI0027379
- Product descriptionELUXADOLINE 95.00%
- Packaging5MG
- Price$504.41
- Updated2021-12-16
- Buy
- ManufacturerCayman Chemical
- Product number21522
- Product descriptionEluxadoline ≥98%
- Packaging10mg
- Price$63
- Updated2021-12-16
- Buy
- ManufacturerCayman Chemical
- Product number21522
- Product descriptionEluxadoline ≥98%
- Packaging25mg
- Price$149
- Updated2021-12-16
- Buy
- ManufacturerCayman Chemical
- Product number21522
- Product descriptionEluxadoline ≥98%
- Packaging50mg
- Price$280
- Updated2021-12-16
- Buy
- ManufacturerCayman Chemical
- Product number21522
- Product descriptionEluxadoline ≥98%
- Packaging5mg
- Price$293
- Updated2021-12-16
- Buy
- ManufacturerDC Chemicals
- Product numberDC8626
- Product descriptionEluxadoline >98%
- Packaging100mg
- Price$350
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberE508195
- Product descriptionEluxadoline
- Packaging100mg
- Price$640
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| American Custom Chemicals Corporation | API0027379 | ELUXADOLINE 95.00% | 5MG | $504.41 | 2021-12-16 | Buy |
| Cayman Chemical | 21522 | Eluxadoline ≥98% | 10mg | $63 | 2021-12-16 | Buy |
| Cayman Chemical | 21522 | Eluxadoline ≥98% | 25mg | $149 | 2021-12-16 | Buy |
| Cayman Chemical | 21522 | Eluxadoline ≥98% | 50mg | $280 | 2021-12-16 | Buy |
| Cayman Chemical | 21522 | Eluxadoline ≥98% | 5mg | $293 | 2021-12-16 | Buy |
| DC Chemicals | DC8626 | Eluxadoline >98% | 100mg | $350 | 2021-12-16 | Buy |
| TRC | E508195 | Eluxadoline | 100mg | $640 | 2021-12-16 | Buy |
Properties
Melting point :>180°C (dec.)
Boiling point :834.2±65.0 °C(Predicted)
Density :1.284±0.06 g/cm3(Predicted)
storage temp. :Refrigerator
solubility :DMSO (Slightly), Methanol (Slightly)
form :Solid
pka :4.01±0.10(Predicted)
color :White to Off-White
InChIKey :QFNHIDANIVGXPE-FNZWTVRRSA-N
SMILES :C(O)(=O)C1=CC(CN(C(=O)[C@@H](N)CC2=C(C)C=C(C(N)=O)C=C2C)[C@H](C2NC(C3=CC=CC=C3)=CN=2)C)=CC=C1OC
CAS DataBase Reference :864821-90-9
Boiling point :834.2±65.0 °C(Predicted)
Density :1.284±0.06 g/cm3(Predicted)
storage temp. :Refrigerator
solubility :DMSO (Slightly), Methanol (Slightly)
form :Solid
pka :4.01±0.10(Predicted)
color :White to Off-White
InChIKey :QFNHIDANIVGXPE-FNZWTVRRSA-N
SMILES :C(O)(=O)C1=CC(CN(C(=O)[C@@H](N)CC2=C(C)C=C(C(N)=O)C=C2C)[C@H](C2NC(C3=CC=CC=C3)=CN=2)C)=CC=C1OC
CAS DataBase Reference :864821-90-9
Safety Information
| Symbol(GHS): |
|
||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal word: | Warning | ||||||||||||||
| Hazard statements: |
|
||||||||||||||
| Precautionary statements: |
|
Description
Eluxadoline, originally developed by Janssen and currently marketed by Allergan (formerly Actavis), was approved in May 2015 by the FDA for the treatment of diarrhea-predominant irritable bowel syndrome (IBS-D). Eluxadoline, an orally dosed agent, employs a unique mechanism for IBS-D treatment, as it functions simultaneously as a μ- and κ-opioid receptor agonist and a δ- opioid receptor antagonist, leading to a first-in-class therapy for treatment of IBS-D. Specifically, in animal studies, eluxadoline was found to interact with opioid receptors in the gut, inhibiting neurogenically mediated secretion and reducing intestinal contractility. Additionally, the treatment led to a decrease in stress-induced acceleration of upper GI transit without causing rebound constipation, earning its mark as a first-line therapeutic treatment for IBS-D. In two phase III clinical trials of over 2400 patients with IBS-D, patients taking eluxadoline showed a greater improvement toward the end point (≥30% improvement from their baseline IBS-D score on at least 50% of days treated with eluxadoline) compared to patients treated with placebo.Related product price
- Axitinib
$39-1154 - Bicalutamide
$30-1593.9
Suppliers and manufacturers
Protheragen-ING
Capot Chemical Co.,Ltd.
Beijing Cooperate Pharmaceutical Co.,Ltd
Henan Tianfu Chemical Co.,Ltd.
ATK CHEMICAL COMPANY LIMITED
Nanjing Dolon Biotechnology Co.,Ltd.
Hangzhou Cyanochem Co., Ltd.
